G
Guardant Health
GH
33.380
USD
-1.77
(-5.04%)
مفتوح الان
حجم التداول
24,348
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
2,524,413,000
العنوان: Guardant Health
القطاع: Healthcare
الصناعة: Diagnostics & Research
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD,test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.